IQVIA HOLDINGS INC. (IQV)
D
Pipeline Grade
Financial Position (from SEC Filings)
$1,947.0M
Cash & Equivalents
$618.0M
Quarterly Burn Rate
$34,690M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-08-14 | Phase3 Readout | — |
| 2026-11-05 | Phase2 Readout | — |
| 2026-12-26 | Phase3 Readout | — |
| 2027-01-30 | Phase2 Readout | — |
| 2027-02-01 | Phase2 Readout | — |
| 2027-06-14 | Phase2 Readout | — |
Active Clinical Trials (33)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07000110 | Anifrolumab Malignancy and Serious Infections Study | OTHER | Recruiting | 3,195 |
| NCT06712563 | Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting | OTHER | Recruiting | 2,000 |
| NCT05776472 | A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) | OTHER | Recruiting | 200 |
| NCT03193476 | Registry for Patients With X-Linked Hypophosphatemia | OTHER | Recruiting | 1,489 |
| NCT06797258 | FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction | OTHER | Recruiting | 259 |
| NCT07603193 | Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream | OTHER | Enrolling By Invitation | 1,000 |
| NCT06716801 | Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain | OTHER | Recruiting | 300 |
| NCT04280029 | SELUTION SLR™ 014 In-stent Restenosis | OTHER | Active Not Recruiting | 418 |
| NCT04201132 | Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System | OTHER | Active Not Recruiting | 305 |
| NCT05663515 | A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated E... | OTHER | Recruiting | 24,000 |
| NCT03297281 | Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) | OTHER | Recruiting | 389 |
| NCT05835349 | Observational Study of Venus P-Valve | OTHER | Recruiting | 200 |
| NCT07377682 | Real-world Clinical Response to Trazodone in Italy, Poland, and Romania | OTHER | Recruiting | 120 |
| NCT07049653 | Anifrolumab Pregnancy Study | OTHER | Recruiting | 500 |
| NCT06412250 | A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry) | OTHER | Recruiting | 2,000 |
| NCT06498128 | Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ® | OTHER | Recruiting | 785 |
| NCT05859854 | Cenobamate in Adults With Focal-Onset Seizures | OTHER | Active Not Recruiting | 936 |
| NCT06951867 | Tezspire Cardiac Events PASS | OTHER | Recruiting | 16,640 |
| NCT07405983 | TOUCH® CMC 1 New Enrollment US Study | OTHER | Recruiting | 163 |
| NCT06559891 | THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatmen... | OTHER | Recruiting | 261 |
| NCT06938854 | Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries | OTHER | Active Not Recruiting | 81 |
| NCT06073652 | Starter Infant Formula With Synbiotics | OTHER | Active Not Recruiting | 240 |
| NCT05267613 | Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. | PHASE3 | Active Not Recruiting | 53 |
| NCT04498117 | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Su... | PHASE3 | Active Not Recruiting | 615 |
| NCT05101187 | Olorofim Aspergillus Infection Study | PHASE3 | Active Not Recruiting | 225 |
| NCT04877691 | Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus | PHASE3 | Active Not Recruiting | 367 |
| NCT04980638 | Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia | PHASE2 | Recruiting | 20 |
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | PHASE2 | Recruiting | 1,000 |
| NCT02734004 | A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. | PHASE2 | Active Not Recruiting | 264 |
| NCT06504446 | Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough | PHASE2 | Active Not Recruiting | 455 |
| NCT06549946 | Ixovex-1 Single Agent and Combination Therapy | PHASE2 | Recruiting | 18 |
| NCT07517445 | Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susc... | PHASE2 | Recruiting | 165 |
| NCT07525427 | Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis | PHASE2 | Recruiting | 150 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.